The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 28, 2020

Filed:

Aug. 09, 2018
Applicant:

I-mab, Grand Cayman, KY;

Inventors:

Lei Fang, Shanghai, CN;

Zhengyi Wang, Shanghai, CN;

Bingshi Guo, Shanghai, CN;

Jingwu Zang, Shanghai, CN;

Assignee:

I-Mab Biopharma US Limited, Gaithersburg, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 39/395 (2006.01); A61P 31/20 (2006.01); A61P 31/14 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01); A61P 31/18 (2006.01); A61P 31/22 (2006.01); A61P 31/08 (2006.01); A61P 31/04 (2006.01); A61P 31/06 (2006.01); A61P 31/16 (2006.01); A61K 35/17 (2015.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2827 (2013.01); A61K 35/17 (2013.01); A61P 31/04 (2018.01); A61P 31/06 (2018.01); A61P 31/08 (2018.01); A61P 31/14 (2018.01); A61P 31/16 (2018.01); A61P 31/18 (2018.01); A61P 31/20 (2018.01); A61P 31/22 (2018.01); A61P 35/00 (2018.01); A61P 35/02 (2018.01); A61K 2039/505 (2013.01); A61K 2039/5158 (2013.01); A61K 2039/575 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/32 (2013.01); C07K 2317/33 (2013.01); C07K 2317/52 (2013.01); C07K 2317/565 (2013.01); C07K 2317/567 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01);
Abstract

Provided are anti-PD-L1 antibodies or fragments thereof. The antibodies or fragments thereof specifically bind to the immunoglobulin C domain of the PD-L1 protein. In various example, the antibodies or fragments thereof include a VH CDR1 of SEQ ID NO: 1, a VH CDR2 of SEQ ID NO: 2, a VH CDR3 of SEQ ID NO: 3, a VL CDR1 of SEQ ID NO: 4, a VL CDR2 of SEQ ID NO: 5, and a VL CDR3 of SEQ ID NO: 6, or variants of each thereof. Methods of using the antibodies or fragments thereof for treating and diagnosing diseases such as cancer and infectious diseases are also provided.


Find Patent Forward Citations

Loading…